# IBI Investment House

> IBI Investment House is a VC fund backing Medical, Health Care and Life Science. See 2 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Aug 2018
- Lead investor: 50%
- Last updated: Sep 2026
- Website: http://www.ibi.co.il

IBI Investment House is a VC fund focused on Medical and Health Care. IBI Investment House offers investment management & trading services from a mutual fund, provident fund, trading and execution services on portfolio management, investment banking, and foreign currency, among others. Its services are supported by its market-leading research department, which covers 100 of Israel’s top companies, and itseconomics department, which provides coverage of macro-economic developments in Israel and follows trends on global markets.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Debt | 1 | 50% |
| Post-IPO Equity | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Insuline Medical | Insuline Medical Ltd. is a public Israeli company focused on improving the performance of current insulin treatment methods by trying to better approximate human physiology. Even with today’s rapid acting insulin analogs, there is a gap of at least one hour between bolus insulin injection and its peak in the blood system. | $2.9M | Post-IPO Debt | Aug 08, 2018 | http://www.insuline-medical.com/ |
| Brainsway | Brainsway's patented breakthrough technology launches a new era in brain disorder treatment. A non-invasive, yet highly effective solution, Brainsway can make a difference in the wellbeing and health of millions of patients worldwide.Brainsway's technology releases millions of patients from a bleak cycle of insufficiently effectivetreatments and unpleasant side effects. Brainsway's treatment was approved by the FDA for Major Depressive Disorder patients*. The technology is also safe, with no systemic effects or long-term side effects, and highly convenient, requiring only brief daily sessions over a couple of weeks.Brainsway's technology has already been applied in thousands of cases worldwide in the framework of clinical studies. It has also been enthusiastically embraced by leading research institutions worldwide, with over 60 clinical trials performed. Brainsway technology is based on a patent registered by the U.S. National Institutes of Health (NIH).Brainsway is dedicated to research and continuously explores treatments for a variety of brain disorders. | $8.5M | Post-IPO Equity | Dec 11, 2017 | http://www.brainsway.com |

2 of 2 investments shown.

## Co-investors
- [Cybele Holdings](https://shizune.co/investors/profile/cybele-holdings) — VC Fund, 1 deal together
- [Phoenix Financial](https://shizune.co/investors/profile/phoenix-insurance-company) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund
- [Canada Economic Development for Quebec Regions](https://shizune.co/investors/profile/canada-economic-development-for-quebec-regions) — VC Fund
- [UniCredit](https://shizune.co/investors/profile/unicredit) — VC Fund

## FAQ

### What does IBI Investment House invest in?

IBI Investment House invests primarily in Medical, Health Care and Life Science startups, most often at Post-IPO Debt and Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did IBI Investment House last invest?

The most recent investment recorded for IBI Investment House closed in Aug 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co